Dilution of share value through the exercise of stock acquisition rights
First written in FY2022. 10 of 11 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2026.
Gloe moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「As of 30 June 2026, the number of potential shares from these share acquisition rights was 55,161, equivalent to 2.0% of the 2,775,933 issued shares.」
Updated the number of potential shares and potential dilution to 55,161, equivalent to 2.0% of issued shares, following the grant of 13,200 shares under the fourth series of share acquisition rights and other factors. - FY2025MaterialisedAnnual report
「1 November 2024–31 October 2025 (Note 2) 39,741 shares 2,775,933 4,109 152,441 4,109 151,441」
During the fiscal year, 39,741 shares were added through the exercise of share acquisition rights, and share dilution continued to occur. At the end of the period, potential shares totaled 41,961, equivalent to 1.5% of issued shares. - FY2025-H1MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
From 1 November 2024 through 30 April 2025, 27,366 shares were added through the exercise of share acquisition rights, and share dilution continued to occur. A further 9,375 shares were added from 1 May through 13 June 2025. - FY2024MaterialisedAnnual report
「As of the end of December 2024, the number of potential shares from these share acquisition rights was 59,903, equivalent to 2.2% of the 2,762,725 issued shares.」
The exercise of share acquisition rights continued, resulting in dilution through share issuance. Potential shares totaled 59,903, equivalent to 2.2% of issued shares. - FY2024-Q2MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
During the second-quarter accounting period, 1,628 shares were added through the exercise of share acquisition rights, and share dilution has continued to occur. - FY2024-Q1MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
During the cumulative first-quarter period, 9,433 shares were added through the exercise of share acquisition rights, and share dilution has continued to occur. Capital stock and capital surplus also each increased by ¥663 thousand. - FY2023MaterialisedAnnual report
「As of the end of December 2023, the number of potential shares from these share acquisition rights was 90,335, equivalent to 3.3% of the 2,734,431 issued shares.」
Share issuance through the exercise of share acquisition rights continued, updating the potential dilution of 90,335 shares, equivalent to 3.3% of issued shares. - FY2023-Q3MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
From May through July 2023, 8,333 shares were added through the exercise of share acquisition rights, and share dilution has continued to occur. - FY2023-Q2MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
During the second-quarter accounting period, 4,166 shares were added through the exercise of share acquisition rights, and dilution has continued to occur in practice. - FY2023-Q1MaterialisedAnnual report
「Increase from the exercise of share acquisition rights (stock options)」
States that 12,499 shares were added through the exercise of share acquisition rights during the quarter, resulting in actual dilution of per-share value through the exercise of potential shares. - FY2022First statedAnnual report
「As of the end of December 2022, the number of potential shares from these share acquisition rights was 135,701, equivalent to 5.0% of the 2,712,499 issued shares.」
Quantitatively discloses the number of potential shares from stock options and their ratio to issued shares as dilution risk.